4 completed. 4 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 2 | Completed 2 |
Follow Lead: new trials by email Literature Review of Lead trials Research Report on Lead
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days post - Glioblastoma, Adult | Phase 1 / Phase 2 | Completed | Case Comprehensive Cancer Center | 32 | 2017-11-29 | 2026-09-17 |
| Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02) Atu027 & gemcitabine in lead in safety period, Atu027 & gemcitabine in treatment arm 1, Atu027 & gemcitabine in treatment arm 2 - Carcinoma, Pancreatic Ductal | Phase 1 / Phase 2 | Completed | Silence Therapeutics GmbH | 29 | 2013-03-01 | 2016-03-11 |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer pre, during and pos-treatment swallowing exercises - Head Neck Cancer, Swallowing Disorders | Phase 2 | Completed | Barretos Cancer Hospital | 94 | 2012-07-01 | 2017-06-28 |
| Vitamin E for Oxaliplatin-induced Peripheral Neuropathy Prophylaxis Vitamin E, Placebo - Peripheral Neuropathy | Phase 2 | Completed | Felipe Melo Cruz | 38 | 2009-08-01 | 2012-02-01 |
Adenocarcinoma (1) · Brain Neoplasms (1) · Carcinoma, Pancreatic Ductal (1) · Communication Disorders (1) · Deglutition Disorders (1) · Glioblastoma (1) · Head and Neck Neoplasms (1) · Peripheral Nervous System Diseases (1)
Barretos Cancer Hospital (1) · Case Comprehensive Cancer Center (1) · Felipe Melo Cruz (1) · Silence Therapeutics GmbH (1)
Brazil (2) · Germany (1) · United States (1)
Alexandre Jacinto, MD (1) · Auro del Giglio, phD (1) · Dirk Strumberg, Prof.Dr.med. (1) · Juliana Portas, MSC (1) · Luciano S Viana, PHD (1) · Tiffany Hodges, MD (1)